Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association
Article Information
vol. 38 no. 10 1964-1974
PubMed
Published By
Print ISSN
Online ISSN
History
- Published in print September 24, 2015.
Copyright & Usage
© 2015 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.
Author Information
- Richard A. Insel1⇑,
- Jessica L. Dunne1,
- Mark A. Atkinson2,
- Jane L. Chiang3,
- Dana Dabelea4,
- Peter A. Gottlieb5,
- Carla J. Greenbaum6,
- Kevan C. Herold7,
- Jeffrey P. Krischer8,
- Åke Lernmark9,
- Robert E. Ratner3,
- Marian J. Rewers5,
- Desmond A. Schatz2,
- Jay S. Skyler10,
- Jay M. Sosenko10 and
- Anette-G. Ziegler11
- 1JDRF, New York, NY
- 2UF Diabetes Institute, University of Florida, Gainesville, FL
- 3American Diabetes Association, Alexandria, VA
- 4Colorado School of Public Health, University of Colorado, Denver, CO
- 5Barbara Davis Center for Childhood Diabetes, University of Colorado, Aurora, CO
- 6Benaroya Research Institute at Virginia Mason, Seattle, WA
- 7Department of Immunobiology, Yale School of Medicine, New Haven, CT
- 8Department of Pediatrics, Pediatric Epidemiology Center, Morsani College of Medicine, University of South Florida, Tampa, FL
- 9Lund University/Clinical Research Centre, Skåne University Hospital, Malmö, Sweden
- 10Diabetes Research Institute, University of Miami, Miami, FL
- 11Institute of Diabetes Research, Helmholtz Zentrum München, Munich and Forschergruppe Diabetes, Klinikum rechts der Isar, Technische Universität München, Neuherberg, Germany
- Corresponding author: Richard A. Insel, rinsel{at}jdrf.org.
Statistics from Altmetric.com
Article usage
In this Issue
October 2015, 38(10)
Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association
Jump to section
- Article
- Abstract
- Introduction
- Overview of Staging of Type 1 Diabetes
- Pre-Stage 1: Genetic Susceptibility and Genetic Risk Detection of Type 1 Diabetes
- Stage 1: Autoimmunity+/Normoglycemia/Presymptomatic Type 1 Diabetes
- Stage 2: Autoimmunity+/Dysglycemia/Presymptomatic Type 1 Diabetes
- Current Benefits of Staging Type 1 Diabetes
- Design of Stage-Specific Clinical Trials to Delay and Prevent Type 1 Diabetes Progression
- Refinement of Staging
- Conclusions and Recommendations
- Article Information
- Footnotes
- References
- Figures & Tables
- Info & Metrics